Cytokinetics CYTK
NASDAQ CYTK
$56.18 +1.04 (+1.89%)
At close: Nov 10, 2026 · 4:00 PM EST

Cytokinetics (CYTK) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Analysis

Cytokinetics (CYTK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Cytokinetics 7.83 Bn 3.24 Bn 47.10 Mn 1.82 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.82 Bn
Jun 30, 2026 1.92 Bn
Mar 31, 2026 1.27 Bn
Dec 31, 2025 1.42 Bn
Sep 30, 2025 1.44 Bn
Jun 30, 2025 1.23 Bn
Mar 31, 2025 1.26 Bn
Dec 31, 2024 1.40 Bn
Sep 30, 2024 1.44 Bn
Jun 30, 2024 1.52 Bn
Mar 31, 2024 808.08 Mn
Dec 31, 2023 824.32 Mn
Sep 30, 2023 740.61 Mn
Jun 30, 2023 779.90 Mn
Mar 31, 2023 889.82 Mn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 1.08 Bn
Jun 30, 2022 771.72 Mn
Mar 31, 2022 856.25 Mn
Dec 31, 2021 841.32 Mn
API Access

Cytokinetics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CYTK&period=max&api_key=YOUR_API_KEY